FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.
(The FASEB Journal. 2000;14:1931-1942.)
© 2000 FASEB

A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression

VLADIMIR A. BOTCHKAREV*,1, NATALIA V. BOTCHKAREVA*,1, KATHRYN M. ALBERS{dagger}, LING-HONG CHEN*, PIA WELKER* and RALF PAUS*2

* Department of Dermatology, Charité, Humboldt University, Berlin, Germany;
{dagger} Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 0536–0084; USA; and
{ddagger} Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany

2Correspondence: Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Martinstrasse 52, D-20246 Hamburg, Germany. E-mail: paus{at}uke.uni-hamburg.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
To examine the mechanisms that underlie the neurotrophin-induced, apoptosis-driven hair follicle involution (catagen), the expression and function of p75 neurotrophin receptor (p75NTR), which is implicated in apoptosis control, were studied during spontaneous catagen development in murine skin. By RT-PCR, high steady-state p75NTR mRNA skin levels were found during the anagen–catagen transition of the hair follicle. By immunohistochemistry, p75NTR alone was strongly expressed in TUNEL+/Bcl2- keratinocytes of the regressing outer root sheath, but both p75NTR and TrkB and/or TrkC were expressed by the nonregressing TUNEL-/Bcl2+ secondary hair germ keratinocytes. To determine whether p75NTR is functionally involved in catagen control, spontaneous catagen development was compared in vivo between p75NTR knockout (-/-) and wild-type mice. There was significant catagen retardation in p75NTR knockout mice as compared to wild-type controls (P<0.05). Instead, transgenic mice-overexpressing NGF (promoter: K14) showed substantial acceleration of catagen (P<0.001). Although NGF, brain-derived neurotrophic factor (BDNF), and neurotrophin 3 (NT-3) accelerated catagen in the organ-cultured skin of C57BL/6 mice, these neurotrophins failed to promote catagen development in the organ-cultured p75NTR null skin. These findings suggest that p75NTR signaling is involved in the control of kerotinocyte apoptosis during catagen and that pharmacological manipulation of p75NTR signaling may prove useful for the treatment of hair disorders that display premature entry into catagen.—Botchkarev, V. A., Botchkareva, N. V., Albers, K. M., Chen, L.-H., Welker, P., Paus, R. A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression.


Key Words: p75NTR • kerotinocyte catagen • NGF • NT-3 • BDNF • alopecia


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
THE HAIR FOLLICLE (HF) represents a hair shaft-producing mini-organ that shows a cyclic activity during postnatal development with alternating periods of active growth (anagen), regression (catagen), and resting (telogen) (1 2 3 4) . This cyclic activity of the HF is governed by epithelial–mesenchymal interactions between keratinocytes (KC) of the hair bulb and fibroblasts of the dermal papilla (DP), and every hair cycle stage is regulated by the balance of numerous growth stimulatory and inhibitory factors (2 3 4 5) .

The hair follicle transformation from active growth to regression (anagen–catagen transition) is characterized by a sudden decline in the DP secretion of growth factors for hair matrix KC, leading to the dramatic reduction of their proliferative activity, termination of hair shaft production, and shortening of the HF length up to 70% due to massive apoptosis in the proximal HF epithelium (6 7 8 9) . The molecular control of HF regression has long fascinated developmental biologists and dermatologists, and important roles for such growth factors as fibroblast growth factor 5, insulin-like growth factor 1, transforming growth factor ß, and PTHrp in catagen development have been shown during the last decade (3 , 5 , 10 11 12 13 14 15 16) .

Recently we have demonstrated that neurotrophins, a family of structurally and functionally related polypeptides that includes nerve growth factor (NGF), neurotrophin 3 (NT-3), brain-derived neurotrophic factor (BDNF), and neurotrophin 4 (NT-4), are also intimately involved in the control of HF anagen–catagen transformation (17 , 18) . Neurotrophins exert their biological effects via interaction with high-affinity receptors (TrkA is a specific receptor for NGF, TrkB, and TrkC—receptors for BDNF/NT-4 and NT-3, respectively), as well as via low affinity binding to the p75 neurotrophin receptor (p75NTR) (cf. 19–21). NT-3 is able to interact with low affinity with TrkA and TrkB, but binds with high affinity to p75NTR (21 , 22) .

The importance of neurotrophins for the anagen–catagen transformation of the HF in mice was demonstrated in different models: expression of NT-3, BDNF, and NT-4 is up-regulated in the regressing HF compartments during catagen in C57BL/6 mice; mouse mutants with overexpression or deletion of neurotrophins show alterations in catagen development and in hair shaft length; finally, NT-3, BDNF, and NT-4-stimulate catagen in murine skin organ culture (17 , 18) .

Although both types of neurotrophin receptors (high-affinity receptors of Trk family and low affinity p75NTR) are expressed in the regressing HF compartments during catagen (9 , 17 , 18) , their precise roles in catagen control remain to be elucidated. However, an involvement of p75NTR in the control of KC apoptosis during HF regression is suggested because p75NTR is known to modulate cell death in different models (23 24 25 26 27 28 29) and HF regression is the essentially apoptosis-driven process (8 , 9 , 30 31 32) .

p75NTR is a member of a family of structurally related cytokine receptors (TNF type I and II receptors, Fas-Apo1 receptor, CD40, CD30, CD27), characterized by an extracellular domain with repeated cysteine clusters and by an intracellular domain containing a serine/threonine-X-valine carboxy-terminal motif similar to that of Fas and TNFRI, referred to as a ‘death domain’ (reviewed in refs 33 34 35 36 ). Proapoptotic signaling effects of p75NTR occur when p75NTR is expressed alone, without coexpression with high-affinity neurotrophin receptors TrkA, TrkB, or TrkC. In contrast, apoptotic cell death mediated via p75NTR signaling does not occur if p75NTR is coexpressed with high-affinity Trk receptors (35 36 37 38 39) . In this case, p75NTR promotes signaling transduction through Trk receptors and hence cell survival. Thus, the pro- or anti-apoptotic action of neurotrophins is strongly dependent on the relative expression of p75NTR and Trk receptors on target cell populations.

To explore the role for p75NTR in HF regression, we studied the expression and coexpression patterns of p75NTR, Trk receptors, and apoptotic markers in the regressing HF compartments during catagen, using a C57BL/6 mouse model (40 , 41) with semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR), double and triple immunofluorescence techniques, and in situ end labeling (TUNEL). The dynamics of catagen development were assessed histomorphometrically in p75NTR knockout (-/-) mice and in NGF-overexpressing mice. In addition, the effects of neurotrophins on HF regression were compared in the organ-cultured skin of C57BL/6 and p75NTR null mice.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Animal models and tissue collection
C57BL/6 mice and p75NTR knockout (-/-) mice were purchased from Charles River (Sulzfeld, Germany) and Jackson Laboratory (Bar Harbor, Mass.), respectively. Mice were housed in community cages at the animal facilities of the Charité (Campus Virchow Clinic, Humboldt University, Berlin). NGF-overexpressing mice were housed at the animal facility of the Kentucky University Medical Center. All mice were fed water and mouse chow ad libitum, and were kept under 12 h light/dark cycles.

Homozygous p75NTR knockout (-/-) mice were generated using conventional gene targeting techniques under C57BL/6 background, as described previously (42) . NGF-overexpressing transgenic mice were generated using K14 as promoter, which ensures strong expression of NGF in the basal epidermal KC and KC of the HF outer root sheath (43) . Genotyping of mutant animals was performed using PCR protocols for the mutated alleles and slot blot analysis of isolated tail DNA (44) . Both mouse strains are viable and fertile and display no obvious, macroscopically visible hair growth abnormalities.

Active hair growth (anagen) was induced as described (40) in the back skin of 6- to 9-wk-old C57BL/6 female mice or in 8-wk-old p75NTR knockout (-/-) and their corresponding age-matched wild-type mice in the telogen phase of the hair cycle. In both mouse strains, HF anagen–catagen transformation was studied, using at least four mice per time point: anagen VI (12 days after anagen induction by depilation [12 days p.d.]), catagen II, IV, VI-VIII (17–19 days p.d.) (1 , 6 , 40 , 41) .

For the analysis of spontaneous hair follicle cycling in infantile p75NTR knockout (-/-), NGF-overexpressing, and the corresponding wild-type mice, skin was harvested 14–20 days after birth (P14-P20); four to seven mice of every strain were studied. In all experiments, the neck region of the back skin was harvested parallel to the vertebral line and embedded using a special technique for obtaining longitudinal cryosections through the HF from one defined site (45) .

RT-PCR
Total RNA was isolated from full-thickness back skin samples (homogenized in liquid nitrogen), using a single-step guanidine thiocyanate-phenol-chloroform method using RNeasy-total-RNA-kit (Quiagen, Hilden, Germany). Skin samples included the subcutaneous skeletal (panniculus carnosus) muscle layer. cDNA was synthesized by reverse transcription of 3 µg total RNA, using a cDNA synthesis kit (Invitrogen, San Diego, Calif.). The following sets of oligonucleotide primers were used to amplify specific c-DNA: ß-actin: 5'-GAA AAC GCA GCT CAG TAA CAG TCC G and 5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3'; p75NTR: 5'-GCAGGGCGGCTAAAAGGGCATCAAG-3' and 5'-CACATACTCAGACGAAGCCAACCACG-3' (46) . Amplification was performed using taq polymerase (Life Technologies, Inc., Grand Island, N.Y.) over 34 cycles, using an automated thermal cycler (Perkin Elmer Cetus, Norwalk, Conn.). Each cycle consisted of the following steps: denaturating at 94°C (1 min), annealing at 60°C (45 s), and extension at 72°C (45 s). PCR products were analyzed by gel electrophoresis (2% agarose) and enzymatic digestion using standard methods (17 , 18) . For semiquantitative RT-PCR, linear correlation of signal intensity for ß-actin was found between 24 and 27 cycles, and for the p75NTR between 30 and 35 cycles using a video scanner system Scan Pack 2.0 (Biometra, Göttingen, Germany). This allowed for the demonstration of clearly different signals, as compared to control signals.

Immunohistochemistry
All antisera used are listed in Table 1 . For the double immunodetection of p75NTR-immunoreactivity (IR) on the one hand, and TrkA-, TrkB-, or TrkC-IR on the other, the tyramide amplification method was used (17 , 18) . Briefly, after blocking of endogenous peroxidase and nonspecific avidin/biotin binding, sections were incubated in TNB buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and 0.5% DuPont Blocking Reagent, DuPont NEN, Boston, Mass.) for 30 min. Then rat monoclonal antibody against mouse p75NTR was applied overnight (1:1000), followed by application of the biotinylated goat anti-rat antiserum diluted in TNB blocking buffer (DuPont NEN, 1:200, 30 min), and a tyramide amplification kit (DuPont NEN). Subsequently, sections were incubated in streptavidin-horseradish peroxidase (1:100 in TNB, 30 min). Three washes with TNT buffer (0.1 M Tris-HCl, pH 7.6, 0.15M NaCl, 0.05% Tween) were followed by a 10 min application of TRITC-tyramide (1:50 in Amplification Diluent, DuPont NEN). After blocking nonspecific binding by 10% of normal goat serum, sections were incubated with rabbit antisera against TrkA, TrkB, or TrkC (1:50, overnight at room temperature), washed in TBS (3x5 min), followed by incubation with Cy2-conjugated goat anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, Pa., 1:20, 37°C, 1 h). Finally, sections were washed three times with Tris buffer and counterstained by Hoechst 33342 for identification of cell nuclei (9 , 47) .


View this table:
[in this window]
[in a new window]
 
Table 1. Primary antibodies

Double immunovisualization of p75NTR- and Bcl-2-IR was performed as described previously (9) , using rat monoclonal antibody against p75NTR and hamster monoclonal antibody against murine Bcl-2 (see Table 1 ). For all antisera, incubation of skin sections without primary antisera and skin cryosections from p75NTR, TrkA, TrkB, and TrkC knockout mice were used as negative control. In addition, for antisera against Trk receptors, the preabsorption of primary antisera with 100 µg/ml of corresponding antigenic peptides (37°C, 60 min) was used as negative control. Cryostat sections of the whole-mount mouse embryos at E18.5 with differential distribution of p75NTR and Trk receptors served a positive control for immunostaining. All sections were examined under a Zeiss Axioscope microscope and photo-documented with the help of a digital image analysis system (ISIS MetaSystem, Altlussheim, Germany).

Double immunodetection of TUNEL-positive cells and p75NTR-IR
To evaluate apoptotic cells, we used an established, commercially available TUNEL kit (ApopTag, Oncor, Gaithersburg, Md.) as described before (9 , 47) . For double immunofluorescence detection of TUNEL-positive cells and p75NTR-IR, sections were incubated with digoxigenin-dUTP in the presence of TdT, followed by incubation with rabbit-anti-TrkB antiserum. Subsequently, TUNEL-positive cells were visualized by anti-digoxigenin FITC-conjugated F(ab)2 fragments, p75NTR-IR was detected by a tyramide amplification kit using biotinylated goat-anti-rat antibody, streptavidin-horseradish peroxidase, and TRITC-tyramide as described above, and sections were counterstained by Hoechst 33342 (9 , 47) . Negative controls for the TUNEL staining were made by omitting TdT, according to the manufacturer’s protocol. Positive TUNEL controls were run, as described (47) , by comparison with tissue sections from the thymus of young mice, which display a high degree of spontaneous thymocyte apoptosis (9).

Skin organ culture
Four millimeter punch biopsies were prepared under sterile conditions from either neonatal C57BL/6 mice or neonatal p75NTR knockout mice at P17, i.e., at the beginning of the anagen–catagen transformation of the HF (48) , following previously described protocols (49 , 50) with some modifications. Eight to 10 randomized skin punches derived from the back skin of three different mice per experimental group were placed (dermis down) on gelatin sponges (Gelfoam, Upjohn Co., Kalamazoo, Mich.) in 35 mm Petri dishes containing 5 ml Dulbecco’s modified Eagle’s medium, 10% fetal bovine serum, 50 mg/ml L-glutamine, and antibiotic/antimycotic mixture (Life Technologies, Inc.). After addition of 250 ng/ml of mouse 2.5S NGF (Boehringer Mannheim, Mannheim, Germany), 50 ng/ml of human recombinant NT-3 (Promega, Madison, Wis.), or 5 ng/ml of human recombinant BDNF (Promega), skin fragments were incubated at the air-liquid interphase for 48 h at 37°C, in 5% CO2 and 100% humidity. At the end of incubation, all skin fragments were washed repeatedly in phosphate-buffered saline buffer at 4°C, fixed in 4% paraformaldehyde, and embedded in paraffin for routine histology and histomorphometry.

Histomorphometry and statistical analysis
In adolescent skin, IR patterns were scrutinized by studying at least 50 different HF per mouse; five mice were assessed per hair cycle stage. For each stage of HF cycling, the major IR patterns were recorded in previously prepared, computer-generated schematic representations of murine HF cycling, which allow a standardized, easily reproducible, and systematic comparison of different follicular IR patterns (14) . For precise identification of the defined stages of HF cycling, histochemical detection of endogenous alkaline phosphatase activity was used as described, since this allows one to visualize the morphology of the dermal papilla as a useful morphological marker for staging HF cycling (51) .

The percentage of HF in different stages of growth (anagen), regression (catagen), or resting (telogen) was assessed and calculated in p75NTR knockout (-/-) and NGF-overexpressing mice at P14-P20, respectively, as well as in their corresponding age-matched wild-type mice. During these days of postnatal development, the hair follicle, after completion of morphogenesis, begins its life-long cycle of regression, resting, and growth by spontaneous entry into the first catagen stage (2 , 4) . In normally cycling mice this occurs around P17, and at P20–22 all hair follicles in back skin reach the resting (telogen). All evaluations were performed on the basis of accepted morphological criteria of HF classification (1 2 3 4 , 6 , 52) . Only every tenth cryosection was used for analysis in order to exclude the repetitive evaluation of the same HF, and 2–3 cryosections were assessed from each animal. All together, 200–350 follicles in 50–60 microscopic fields, derived from four to seven animals (~50–60 follicles per animal) of distinct age, were analyzed and compared to that of a corresponding number of HF from the appropriate, age-matched wild-type mice. In skin organ culture, the percentage of HF in defined catagen stages was calculated in 8–10 biopsies per group at magnification x400 under a Zeiss Axioscope microscope, following accepted morphological criteria of classifying defined stages of catagen development (6 , 41) .

For quantitative assessment of the dynamics of catagen development (D) during in vivo and in situ experiments, a modified formula, described previously (53) , was used: D = CIx1 + CIIx2 + CIIIx3 + CIVx4 + CVx5 + CVIx6 + CVIIx7 + CVIIIx8, where CI-CVIII = percentage of HF at distinct catagen stages. Then the percentage of the acceleration or retardation of catagen development was evaluated, taking a D value from the corresponding control experiment as 100%.

The distance between the stratum corneum and the subcutis/panniculus carnosus border was measured for assessing the skin thickness in p75NTR knockout, NGF-overexpressing, and corresponding wild-type animals. In total, 40–50 such measurements were performed in 50–60 microscopic fields derived from three to five animals per mutant and wild-type group.

The number of TUNEL-positive cells was assessed in catagen VI-VII HF of p75NTR knockout, NGF-overexpressing, and corresponding wild-type animals at P17-P20. In total, 40–50 such measurements were performed in 50–60 microscopic fields derived from three to five animals per mutant and wild-type group. All sections were analyzed at x200–400 magnification, and means and SE were calculated from pooled data. Differences were judged as significant if the P value was lower than 0.05, as determined by the independent Student’s t test for unpaired samples.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
p75NTR is coexpressed with apoptotic markers in the regressing outer root sheath during catagen
As an important phenomenological indicator for a possible involvement of p75NTR-related signaling in the control of HF regression, p75NTR gene transcription in full-thickness adolescent mouse skin was characterized by semiquantitative RT-PCR analysis during the spontaneous anagen–catagen transformation in the induced, highly synchronized murine hair cycle (40) . High steady-state levels of p75NTR transcripts were detected in skin with all HF at the anagen VI stage (Fig. 1 ). Although during spontaneously developed regression between days 17 and 18 after depilation the p75NTR mRNA PCR-product was reduced vs. anagen VI levels, steady-state levels of p75NTR mRNA were clearly present in catagen skin (Fig. 1) .



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1. Semiquantitative RT-PCR analysis of p75NTR transcript during the hair follicle anagen–catagen transformation. mRNA steady-state levels during the anagen and catagen stages of induced hair cycle. At defined time points, total RNA from full-thickness skin of C57BL/6 mice was extracted and reverse transcribed. A semiquantitative RT-PCR using primers specific for ß-actin and p75NTR was performed. A) Representative gels from one of three experiments (day 12, active hair growth stage [anagen]; day 18, HF regression stage [catagen]). B, C) densitometric analysis of RT-PCR signals specific for ß-actin (B) and p75NTR (C).

To define those cell populations in the catagen HF that express p75NTR alone and therefore represent potential targets for the p75NTR-mediated cell death cf. (22 , 37 , 38 , 54) , coexpression of p75NTR and Trk receptors was studied during spontaneous anagen–catagen transformation in the back skin of adolescent C57BL/6 mice at days 12–19 of induced hair cycle (40) , using a double immunovisualization technique. p75NTR-, TrkA-, TrkB-, and TrkC-IR patterns were each assessed with two distinct antisera (Table 1) , since antibody specificity in discriminating between neurotrophin receptors may be unsatisfactory. However, both antisera against every distinct receptor gave highly similar results in all staining protocols, as well as in the positive and negative controls (not shown). For more extensive analyses, a rat monoclonal antibody against murine p75NTR and antisera against Trk receptors whose expression patterns in murine skin were proven previously by in situ hybridization (indicated by asterisks in Table 1 (18 , 55) were selected, because they provided the best signal/noise ratio. The observed expression and coexpression patterns of p75NTR- and Trk receptor-IR are documented by the representative examples in Fig. 2 and are schematically summarized in Fig. 3 .



View larger version (93K):
[in this window]
[in a new window]
 
Figure 2. Expression and coexpression patterns of p75NTR, Trk receptors, and TUNEL during the anagen–catagen transition. Back skin cryostat sections (8 µm thickness) of adolescent C57BL/6 mice in defined hair cycle stages (anagen VI = 12 days after anagen induction by depilation, catagen II-VI = developed spontaneously 17–19 days after anagen induction) were processed for double immunovisualization of p75NTR- and TrkA-IR (A, D, G), p75NTR- and TrkB-IR (B, E, H), p75NTR- and TrkC-IR (C, F, I), p75NTR-IR and TUNEL (J, K), or p75NTR and Bcl-2 (L). A–C) Anagen VI skin. A) Colocalization of p75NTR- and TrkA-IR in the ORS and keratogenic zone of the hair matrix (arrows). Single immunolabeling for TrkA in the IRS (arrowheads). B) Colocalization of p75NTR- and TrkB-IR in central ORS, keratogenic zone of the hair matrix, and skin nerves (arrows). Single immunolabeling for TrkB in proximal ORS and IRS (arrowheads). C) colocalization of p75NTR- and TrkC-IR in central ORS (arrows). Single immunolabeling for TrkC in proximal ORS, IRS, hair matrix, and dermal papilla (arrowheads). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). D–F) Catagen II skin. D) Colocalization of p75NTR- and TrkA-IR in the ORS and keratogenic zone of the hair matrix (arrows). Some cells in the central ORS show single p75NTR labeling (large arrowhead). Single immunolabeling for TrkA is seen in the IRS, hair matrix (small arrowheads). E) Colocalization of p75NTR- and TrkB-IR in central ORS (arrow). Single immunolabeling for TrkB in proximal ORS, IRS, and dermal papilla (arrowheads). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). F) Colocalization of p75NTR- and TrkC-IR in the central ORS (arrow). Single immunolabeling for TrkC in the proximal ORS, IRS, hair matrix, and dermal papilla (small arrowheads), and for p75NTR in the central ORS and keratogenic zone of hair matrix (large arrowheads). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). G–I) Catagen VI skin. G) Single immunolabeling for p75NTR in the ORS, secondary hair germ, and skin nerves (large arrowheads). TrkA-IR is seen only in single cells of the epithelial strand (small arrows). H) Colocalization of p75NTR- and TrkB-IR in secondary hair germ (arrows). Single immunolabeling for p75NTR in ORS (large arrowheads), and for TrkB in the epithelial strand (small arrowhead). I) Colocalization of p75NTR- and TrkC-IR in secondary hair germ (arrow). Predominance of p75NTR over TrkC in the ORS (large arrowhead) and single immunolabeling for TrkB in the IRS (small arrowhead). J) Colocalization of p75NTR-IR and TUNEL in ORS KC (arrow). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). K) Single labeling for p75NTR in the secondary hair germ (large arrowhead) and for TUNEL in the epithelial strand (small arrowheads). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). L) Single labeling for p75NTR in the ORS (arrows) and for Bcl-2 in dermal papilla (large arrowhead). Colocalization of p75NTR- and Bcl-2-IR is seen in single cells of the secondary hair germ (small arrowheads). Abbreviations: DP, dermal papilla; ES, epithelial strand; HM, hair matrix; HS, hair shaft; IRS and ORS, inner and outer root sheath, respectively; Mel, melanin; SHG, secondary hair germ. Scale bars: A—I) 100 µm, J—L) 50 µm.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 3. Schematic representation of p75NTR and Trk receptors expression in the hair follicle during anagen–catagen transformation. Those cell populations with p75NTR-IR expression are depicted as black circles, Trk-IR are shown with open circles, and colocalization of p75NTR- and Trk-IR is indicated in gray. The different stages of hair cycle are indicated according to refs 1 , 6 . The summary schemes were derived from analyzing >50 longitudinally sectioned follicles from the lower back of 5 C57BL/6 mice harvested per time point. Abbreviations: APM, arrector pili muscle; DP, dermal papilla; E, epidermis; ES, epithelial strand; HM, hair matrix; HS, hair shaft; IRS and ORS, inner and outer root sheath; SG, sebaceous gland; SHG, secondary hair germ.

In general, the follicular patterns of expression for p75NTR, TrkA, TrkB, and TrkC receptors during anagen–catagen transformation defined here are in line with those described in our previous studies (9 , 17 , 18 , 56) . We found that in anagen VI HF (day 12 p.d.), p75NTR-IR was expressed by KC of the proximal and central outer root sheath (ORS), where its coexpression with TrkA-, TrkB-, and TrkC-IR was seen (Fig. 2A , B , C , Fig. 3 ). However, using a more sensitive immunodetection assay than before (9) , the expression of p75NTR-IR was also detected among the melanin granules in the keratogenous zone of the hair matrix, just above and around the most distal part of the dermal papilla (Fig. 2A , B , C ). Here, a colocalization of p75NTR- and TrkA/TrkB-IR was seen (Fig. 2A ). No isolated p75NTR-IR alone, i.e., without its coexpression with Trk receptors, was observed in the anagen VI HF, whereas all Trk receptors were expressed in the follicular inner root sheath (IRS) and hair matrix; relatively weak TrkB- and TrkC-IR expression was detected in the dermal papilla (Fig. 2A , B , C ).

During the onset of HF regression (catagen II, day 17 p.d.), the coexpression of p75NTR- and TrkA-, TrkB-, or TrkC-IR was still visible in the central and proximal ORS; also, coexpression of p75NTR- and TrkA-IR was seen in the keratogenous zone of the hair matrix (Fig. 2D , E , F , Fig. 3 ). In addition, expression of all Trk receptors was observed in the IRS and hair matrix, and weak TrkB-IR was detected in the dermal papilla (Fig. 2D , E , F ).

During further progression of catagen development (catagen IV-VI, days 18–19 p.d.), disappearance of TrkA and TrkB receptors and a substantial decline of TrkC were observed in the regressing ORS, where prominent p75NTR-IR, expressed alone, was still visible (Fig. 2G , H , I , Fig. 3 ). However, coexpression of p75NTR- and TrkB-/TrkC-IR was found in the secondary hair germ of the catagen VI HF (Fig. 2H , 2I ). No p75NTR-IR was observed in the epithelial strand, whereas prominent TrkA-IR expression was seen in single cells located there (Fig. 2G ). TrkB- and TrkC-IR expressed alone were found in the epithelial strand, secondary hair germ, and IRS of the catagen VI HF (Fig. 2H , 2I ).

To define whether or not cells of the regressing HF compartments that express p75NTR are colocalized with apoptotic markers during catagen, a double visualization of p75NTR-IR and TUNEL or p75NTR and Bcl-2 was performed. Only cells in the regressing ORS expressed p75NTR alone in catagen VI HF and showed colocalization of p75NTR and TUNEL (Fig. 2J ); no coexpression of p75NTR- and Bcl-2-IR was seen. In the secondary hair germ, where p75NTR was coexpressed with TrkB and TrkC (Fig. 2H , 2I ; Fig. 3 ), colocalization of p75NTR- and Bcl-2-IR was found (Fig. 2L ) and no coexpression of p75NTR and TUNEL was seen (Fig. 2K ). Strong expression of Bcl-2-IR was observed in the dermal papilla, whereas numerous TUNEL-positive cells were visible in the epithelial strand, an HF compartment that showed no p75NTR-IR and only relatively weak Bcl-2-IR during catagen (Fig. 2K , 2L ).

Taken together, these morphological data suggest that p75NTR-related signaling plays a role in the control of apoptosis-driven HF regression, consistent with recent reports that NGF and BDNF can induce apoptosis via p75NTR in other model systems (23 24 25 , 28) .

Deletion of p75NTR leads to the retardation of hair follicle regression
To determine whether p75NTR deletion alters spontaneous catagen development, adolescent p75NTR knockout (-/-) mice (42) were compared for the speed of spontaneous HF regression after hair cycle induction by depilation, using age-matched wild-type mice as a controls. In addition, the dynamics of the first catagen development was assessed in mutant and wild-type mice at P18-P20, as described previously (17 , 18) .

During the depilation-induced hair cycle, p75NTR knockout mice showed a significant (P<0.01) retardation of catagen development by 42.2% compared to wild-type controls. At day 19 postdepilation, more than half of the HF in p75NTR null skin were still in catagen II-IV, whereas exclusively catagen VI-VIII HF were seen in wild-type skin (Fig. 4A , C , D ). In addition, skin thickness, an important indicator of advanced catagen development (57 , 58) , was significantly reduced (P<0.001) in wild-type mice compared to p75NTR mutants (Fig. 4B ).



View larger version (72K):
[in this window]
[in a new window]
 
Figure 4. Retardation of hair follicle regression in p75NTR knockout (-/-) mice. For hair cycle staging, skin cryosections of adolescent p75NTR knockout (-/-) and wild-type mice at day 19 after depilation were processed to detect endogenous alkaline phosphatase activity (51) ; percentage of HF in defined catagen stages and skin thickness were evaluated according to well-defined morphological criteria (6 , 41 , 58) , A–D) The number of TUNEL-positive cells in catagen VI HF was compared between infantile p75NTR knockout and age-matched wild-type mice at P20 (E–I). A–D) Dynamics of hair follicle regression in adolescent p75NTR knockout mice. Wild-type skin displayed significant predominance of HF in the latest catagen stages at day 19 after depilation (A, C) characterized by their location at the dermis-subcutis border, their shortening to almost telogen length, and a maximally condensed dermal papilla. Compared to wild-type mice, p75NTR knockout (-/-) mice displayed a significantly enhanced number of catagen III-V HF, reduced number of catagen VI HF (whose dermal papilla is still located deep in the subcutis; D), and absence of catagen VII-VIII HF (A, D). HF of distinct catagen stages in panels C, D are indicated by Arabic numbers. Also, skin thickness in mutant mice is significantly higher (P<0.001) than in wild-type controls (B–D). Mean ± SE, asterisks indicates significant differences between identical catagen stages in mutant and wild-type skin, Student’s t test, * P < 0.05, ** P < 0.01. E–I) Selective reduction of TUNEL-positive cells in the ORS of catagen VI HF in p75NTR null skin. E) Graph represents a number of TUNEL-positive cells in the ORS of catagen VI HF in p75NTR knockout and wild-type mice at P20 (mean±SE, asterisks indicates significant differences between mutant and wild-type skin, Student’s t test, * P<0.05). F, G) Three TUNEL-positive cells are visible in the ORS of wild-type HF (F, arrowheads), whereas only one TUNEL-positive cell is seen in two HF of p75NTR null skin (G, arrowhead). H, I) No visible differences in number of TUNEL-positive cells are seen in the epithelial strand between wild-type (H, arrow) and p75NTR deficient skin (I, arrow). Arrowhead in panel H indicates TUNEL-positive cells in the ORS of wild-type HF. Scale bar: 50 µm. Abbreviations: DER, dermis; DP, dermal papilla; ES, epithelial strand; HS, hair shaft; IRS and ORS, inner and outer root sheath, respectively; PCM, panniculus carnosus muscle; SC, subcutis.

Similar differences in the dynamics of catagen development were found between neonatal p75NTR knockout and wild-type mice at P18-P20 (data not shown). Catagen VI HF in neonatal p75NTR knockouts, compared to their age-matched wild-type mice, had a significantly reduced (P<0.05) number of TUNEL-positive cells in the regressing ORS (Fig. 4D , E , F ), whereas the number of TUNEL-positive cells in the epithelial strand and IRS appeared to be unaltered (Fig. 4G , 4H ).

This suggests that deletion of p75NTR is associated with a retardation of catagen development and a reduction of cells undergoing apoptosis in the regressing ORS. This is the same compartment in which p75NTR colocalizes with TUNEL and is not coexpressed with Trk receptors or Bcl-2 during late catagen (Fig. 2G , H , I , J , L ).

Overexpression of NGF is associated with acceleration of catagen development
NGF was the first member of the neurotrophin family described to induce apoptosis via interaction with p75NTR (23 24 25) . We therefore tried to determine whether constitutive NGF overexpression alters spontaneous catagen development. Neonatal transgenic mice with NGF overexpression were compared to age-matched wild-type mice with regard to the onset and speed of spontaneous HF regression. NGF-overexpressing mice were generated using K14 promoter (43) . This is an attractive model for studying the influence of NGF on the anagen–catagen transformation, since K14 targets NGF expression to the follicular ORS KC as well as to KC of the epithelial strand, secondary hair germ, and the base of the club hair (during catagen) (59 60 61) .

After completion of HF morphogenesis, the HF begins its life-long cycle of regression, resting, and growth by spontaneous entry into the first catagen stage (2 3 4) . In normally cycling mice, this occurs around the postnatal day 17 (P17), and by P20-P22 almost all HF are already in the resting stage of the cycle (telogen). At P14, 80–90% of HF in the skin of NGF-overexpressing mice already displayed the morphological characteristics of catagen II follicles, whereas exclusively anagen VI HF were found in the skin of wild-type controls at this time (Fig. 5A , B ). At P17, wild-type control mice still showed no HF in late catagen (stages VII-VIII) (Fig. 5C , 5D ), whereas the HF of NGF-overexpressing mice were already almost all in late catagen (VI-VIII) stages (Fig. 5C , 5E ) and showed acceleration of catagen development by 66.2% compared to wild-type mice. At P20, only telogen HF were found in the skin of NGF-overexpressing mice, whereas 10–20% of follicles in wild-type mice were still in catagen VII-VIII (not shown).



View larger version (66K):
[in this window]
[in a new window]
 
Figure 5. NGF-overexpressing mice show shortening of anagen and acceleration of catagen development. Cryostat sections of back skin of NGF-overexpressing mice and age-matched wild-type mice were generated on day 14 or 17 after birth (P14, P17) and processed for the histochemical detection of endogenous alkaline phosphatase activity at different time points of postnatal development in order to demarcate the dermal papilla shape as a useful marker for hair cycle stage classification (51 ; A–E). The percentage of HF in defined catagen stages (C–E), skin thickness (F), and number of TUNEL-positive cells in the ORS of catagen VII HF (G–I) were evaluated by quantitative histomorphometry in cryostat sections of back skin from NGF-overexpressing and wild-type mice at day 17 after birth (P17). A, B) P14 skin. Wild-type mice show only anagen VI HF, characterized by the oval shape of the large, proximal hair bulb and their large DP (A). In NGF-overexpressing mice, most HF already display shrunken hair bulbs reduced in size as well as a decline in DP size (B), which indicate the onset of catagen development (catagen II-III). Note the presence of numerous thick nerve bundles in the subcutis of transgenic skin (B, NB). C—E) P17 skin. HF of wild-type mice are mostly in mid-catagen (stage IV-VI), which is identifiable by the location of condensed dermal papillae in the lower and mid-subcutis (C, D). Instead, NGF-overexpressing mice at P17 (C, E) display a highly significant increase of HF in the final stages of catagen development (catagen VI-VIII), as evidenced by the shortening of their length and more distally located dermal papillae (which are now located closer to the dermis-subcutis border). Note a presence of numerous thick nerve bundles in the subcutis of transgenic skin (E, NB). HF at the distinct catagen stages are indicated by Arabic numbers. Mean ± SE, asterisks indicates significant differences between identical catagen stages in mutant and wild-type skin, Student’s t test, P < 0.05. Scale bars; 200 µm. Abbreviations: A, anagen VI HF; DER, dermis; NB, nerve bundles; SC, subcutis. F) Graph represents a differences in skin thickness between wild-type and NGF-overexpressing mice at P17. G) Graph represents a number of TUNEL-positive cells in the ORS of catagen VII HF in p75NTR knockout and wild-type mice at P20 (mean±SE, asterisks indicates significant differences between mutant and wild-type skin, Student’s t test, P<0.05). H, I) Only single TUNEL-positive cells are visible in the club hair and epithelial strand of wild-type HF (H, arrow and arrowhead, respectively), whereas numerous TUNEL-positive cells are seen in the follicular ORS and in the epithelial strand in NGF transgenic skin (I, arrows and arrowhead, respectively). Scale bars: 50 µm. Abbreviations: ES, epithelial strand; HS, hair shaft; ORS, outer root sheath.

In addition, compared to wild-type mice, the skin thickness was significantly (P<0.01) lower in NGF-overexpressing mice at P17 (Fig. 5D , E , F ). Since murine skin thickness is strictly coupled to synchronized HF cycling and since catagen and telogen skin is much thinner than anagen skin (57 , 58) , this indicated that the catagen-telogen HF transition in NGF-overexpressing mice had almost been completed at this time point. Furthermore, the number of TUNEL-positive cells in the regressing ORS of the catagen VII HF was significantly enhanced in NGF transgenics compared to wild-type HF (Fig. 5G , H , I ). This suggests that intraepithelial overexpression of the p75NTR ligand NGF accelerates the initiation and/or development of catagen.

Neurotrophins fail to stimulate spontaneous catagen development in organ-cultured p75NTR null skin
Taking into consideration that alterations in HF catagen development observed in p75NTR knockout mice and in NGF transgenics might be connected to the consequences of p75NTR deletion or NGF hyperexpression, such as differences in the skin and hair follicle innervation (42 , 43 , 62 63 64) , the effects of neurotrophins on the anagen–catagen transformation in organ culture (i.e., in the absence of functional skin nerves) were compared between wild-type and p75NTR null skin. Organ culture of murine back skin was selected as an established model for studying of neurotrophin action on hair follicle regression in vitro in the absence of functional skin nerves (17 , 18 , 42 , 50) . NGF, BDNF, or NT-3 were added to organ-cultured skin with most HF in the process of initiating the anagen VI–catagen transformation of the hair cycle. For this purpose, biopsies were taken from neonatal wild-type or p75NTR null mice at P17 (48) and cultured at the air-liquid interphase on gelatin gels (49 , 50) for 48 h in the presence of those concentrations of BDNF or NT-3 that showed maximal catagen-promoting effects in the previous studies (17 , 18) or in the presence of 250 ng/ml of NGF.

We found that all neurotrophins tested significantly promoted spontaneous catagen development in the organ-cultured biopsies of the neonatal wild-type skin (Fig. 6A ) compared to the corresponding vehicle control. This was in line with our data obtained previously on adolescent mouse skin during the depilation-induced hair cycle (17 , 18) . However, NGF, BDNF, and NT-3 failed to induce significant acceleration of HF catagen development in the biopsies of p75NTR null skin compared to vehicle controls (Fig. 6B ). In contrast to wild-type skin, no significant differences in the percentage of HF at distinct catagen stages were seen between biopsies treated with NGF, NT-3, or BDNF and control biopsies taken from p75NTR knockout mice (Fig. 6A , 6B ). However, BDNF showed a slight retardation of catagen by 11.2% in p75NTR null skin, indicating the potential to suppress catagen even in the absence of p75NTR. Instead, NT-3 showed a relatively weak ability to promote catagen by 6.3% in p75NTR knockout skin organ culture, hinting at the possibility of indirect pathways in the NT-3-induced acceleration of catagen (Fig. 6B ).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. NGF, NT-3, and BDNF fail to stimulate catagen development in organ-cultured skin of p75NTR knockout mice. Punch biopsies taken from neonatal back skin of wild-type (A) or p75NTR knockout (-/-) mice (B) at P17 (i.e., with all HF about to enter into the catagen II-catagen III transformation) were incubated during 48 h in the presence of 250 ng/ml of NGF, 50 ng/ml of NT-3, 5 ng/ml of BDNF, or vehicle control, and percentage of HF at the distinct catagen stages was evaluated (mean+SE, n=8–10 biopsies per group, Student’s t test; asterisks indicate significant differences to the vehicle control, * P<0.05). A) Wild-type skin. Acceleration of catagen development by NGF, NT-3, and BDNF. B) p75NTR null skin. Absence of any significant effects of neurotrophins on catagen development.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
HF regression is an example of programmed cyclic organ involution that is tightly controlled by numerous growth factors and their receptors (2 3 4) . Apoptosis is an essential component of HF regression (4) , and dysregulation of apoptosis during catagen leads to alopecia or baldness in experimental and natural models (2 , 9 , 65 66 67 68) . Each anatomic compartment in the cycling portion of HF is characterized during catagen by distinct expression patterns of growth factor receptors implicated in apoptotic cell death (9) . These findings suggest distinct mechanisms of apoptosis regulation in every HF compartment.

We show by multiple criteria that p75NTR signaling is involved in apoptosis in the regressing follicular ORS during catagen: high steady-state levels of p75NTR mRNA are present in skin during the anagen–catagen transition of the HF (Fig. 1) ; p75NTR is not coexpressed with Trk receptors or Bcl-2, but instead colocalizes with TUNEL (Fig. 2G , H , I , J ; Fig. 3 ); p75NTR knockout mice have retarded catagen development and a reduced number of apoptotic cells in the regressing ORS (Fig. 4) ; overexpression of the prototypic p75NTR ligand, NGF, in the follicular ORS is associated with acceleration of catagen (Fig. 5) ; and in contrast to wild-type skin, neurotrophins fail to promote catagen in the organ-cultured skin of p75NTR null mice (Fig. 6) .

Neurotrophins have been reported to induce apoptosis only in cells that express p75NTR alone and do not coexpress Trk receptors (29 , 35 36 37 38 39) . Consistent with these reports, we observed a p75NTR-positive and Trk-negative cell population in the follicular ORS as a potential target for p75NTR-mediated cell death. Indeed, only in the ORS did p75NTR-positive cells coexpress TUNEL, indicative of apoptosis, whereas p75NTR- and TrkB/TrkC-double-positive cells in the secondary hair germ were TUNEL negative, yet positive for Bcl-2, an anti-apoptotic protein (Fig. 2J , K , L ). NGF, NT-3, and BDNF are also prominently expressed in the regressing ORS during catagen (17 , 18 , 56) and thus may induce apoptosis in cells expressing p75NTR in paracrine/autocrine manner.

Participation of the p75NTR receptor in apoptosis does not exclude its simultaneous participation in other HF cells in Trk receptor signaling, such as in the secondary hair germ leading to neurotrophin-mediated cell survival. Indeed, in the secondary hair germ, the HF compartment characterized by predominance of Bcl-2 over Bax during catagen (9) , p75NTR colocalizes with TrkB/TrkC receptors and Bcl-2 (Fig. 2H , 2I , 2L ), but not with TUNEL (Fig. 2K ).

Since deletion of p75NTR in vivo leads to the retardation of HF regression (Fig. 4) , this suggests that proapoptotic signaling through this receptor predominates over any possible survival effects during catagen. The abolishment of p75NTR signaling more effectively retards the late steps of catagen development than early catagen stages. This is consistent with the disappearance of Trk receptors from the regressing ORS during late catagen (Fig. 2) rendering cells vulnerable to activation of p75NTR alone and hence to proapoptotic signaling through p75NTR.

The precise molecular mechanisms of the control of Trk- and p75NTR gene and protein expression, and therefore their ratio, during hair follicle involution remain to be elucidated. However, it was shown in other models that the expression of Trk receptors and p75NTR is specifically controlled by Brn-3a and Sp-1 transcription factors, respectively (69 , 70) . Recently we demonstrated the up-regulation of p75NTR during hair follicle morphogenesis under constitutive deletion of noggin, an antagonist of bone morphogenetic proteins 2 and 4 (71) . This indicates that the upstream effectors of Brn-3a and Sp-1 transcription factors, as well as bone morphogenetic proteins 2/4, might serve as a candidate molecules controlling Trk/p75NTR ratio during the anagen–catagen transition of the HF.

We show here that overexpression of NGF levels in vivo accelerates HF regression (Fig. 5) , which is in line with previous observations that of catagen is stimulated in NT-3 and BDNF transgenic mice (17 , 18) . Although NGF transgenic mice show substantial alterations in cutaneous innervation (43) , our data demonstrating enhanced HF regression in skin organ cultures lacking functional skin nerves (Fig. 6) suggest that catagen stimulatory action of NGF is largely nerve independent.

Compared to other neurotrophins, NGF promoted HF catagen development in organ culture only in relatively high concentrations (Fig. 6) . One possible explanation for this disparity is the greater affinity of NGF for TrkA. If, compared to NT-3 and BDNF, NGF preferentially bound p75NTR in a coordinate manner with TrkA receptors, the effects of NGF would favor survival of cells expressing both receptors rather than apoptosis of cells expressing p75NTR alone. Indeed, the capacity of NGF to suppress KC apoptosis via TrkA stimulation has been shown previously (72) .

Since the ability of NGF to stimulate apoptotic cell death via interaction with TrkA was also shown previously (73 , 74) and neurotrophins could theoretically promote catagen via stimulation of Trk receptors abundantly expressed in the regressing HF compartments during catagen (17 , 18) , followed by the release of other proapoptotic molecules like TNF-alpha, Fas-ligand, or TGF-ß from Trk-positive cell populations, one can also envision p75NTR-independent pathways in the catagen stimulatory action of neurotrophins. However, our data that NGF, BDNF, or NT-3 fail to stimulate HF regression in p75NTR null skin (Fig. 6) clearly suggest an involvement of p75NTR in the realization of the catagen stimulatory activity of neurotrophins. Only slight catagen stimulatory effects of NT-3 were observed in organ-cultured p75NTR null skin (Fig. 6) . This suggests that p75NTR-independent pathways appear to be of relatively little importance compared to direct effects of neurotrophins in p75NTR.

In additional experiments, we have observed that blockade of p75NTR signaling by a synthetic antagonist significantly retards HF catagen development in organ culture of C57BL/6 mouse skin and blocks catagen stimulatory effects of neurotrophins. Furthermore, the p75NTR antagonist failed to retard catagen in the organ-cultured skin of p75NTR knockout mice (Botchkarev et al., unpublished results), which is consistent with the data presented here.

Taken together, our data suggest that cell death during catagen is regulated differentially in every distinct HF compartment and that p75NTR signaling is critically important for apoptosis in the regressing ORS and, therefore, for its shortening during catagen. This raises the possibility of pharmacological manipulation of p75NTR signaling in the treatment of hair disorders that display premature entry into catagen such as telogen effluvium, androgenetic alopecia, and alopecia areata (2).


   ACKNOWLEDGMENTS
 
The critical reading of the manuscript by Drs. B. A. Gilchrest and M. Yaar and the excellent technical assistance of R. Pliet are gratefully acknowledged. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (Pa 345/6–2) and Wella A.G. to R.P. and by a grant from the National Alopecia Areata Foundation to V.A.B.


   FOOTNOTES
 
1 Present address: Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.

Received for publication November 18, 1999. Revision received March 30, 2000.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Chase, H. B. (1954) Growth of the hair. Physiol. Rev. 34,113-126[Free Full Text]
  2. Paus, R. (1996) Control of the hair cycle and hair diseases as cycling disorders. Curr. Opin. Dermatol. 3,248-258
  3. Stenn, K. S., and Paus, R. (2000) Controls of hair follicle cycling. Physiol. Rev. In press
  4. Stenn, K., Parimoo, S., Prouty, S. (1998) Growth of the hair follicle: a cycling and regenerating biological system. Chuong, C.-M. eds. Molecular Basis of Epithelial Appendages Morphogenesis ,111-156 R. G. Landes Austin, Texas.
  5. Paus, R., Cotsarelis, G. (1999) The biology of hair follicles. N. Engl. J. Med. 341,491-498[Free Full Text]
  6. Straile, W. Z., Chase, H. B., Arsenault, C. (1961) Growth and differentiation of hair follicles between activity and quiescence. J. Exp. Zool. 148,205-222
  7. Parakkal, P. F. (1970) Morphogenesis of the hair follicle during catagen. Z. Zellforsch. Mikrosk. Anat. 107,174-186[Medline]
  8. Seiberg, M., Marthinuss, J., Stenn, K. S. (1995) Changes in expression of apoptosis-associated genes in skin mark early catagen. J. Invest. Dermatol. 104,78-82[Medline]
  9. Lindner, G., Botchkarev, V. A., Botchkareva, N. V., Ling, G., van der Veen, C., Paus, R. (1997) Analysis of apoptosis during hair follicle regression (catagen). Am. J. Pathol. 151,1601-1617[Abstract]
  10. Hebert, J. M., Rosenquist, T., Goetz, J., Martin, G. R. (1994) FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 78,1017-1025[Medline]
  11. Philpott, M. P., Sanders, D., Westgate, G. E., Kealey, T. (1994) Human hair growth in vitro: a model for the study of hair follicle biology. J. Dermatol. Sci. 7(Suppl.),S55-S72
  12. Philpott, M. P., Sanders, D. A., Kealey, T. (1994) Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J. Invest. Dermatol. 102,857-861[Medline]
  13. Rudman, S., Philpott, M. P., Thomas, G. A., Kealey, T. (1997) The role of IGF-1 in human skin and appendages: morphogen as well as mitogen?. J. Invest. Dermatol. 109,770-777[Medline]
  14. Paus, R., Foitzik, K., Welker, P., Bulfone-Paus, S., Eichmuller, S. (1997) Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling. J. Invest. Dermatol. 109,518-526[Medline]
  15. Schilli, M., Ray, S., Paus, R., Obi-Tabot, E., Holick, M. F. (1997) Control of hair growth with parathyroid hormone (7–34). J. Invest. Dermatol. 109,928-932
  16. Foitzik, K., Lindner, G., Müller-Röver, S., Maurer, M., Botchkareva, N., Botchkarev, V., Handjiski, B., Metz, M., Hibino, T., Soma, T., Dotto, G. P., Paus, R. (2000) Control of murine hair follicle regression (catagen) by TGF-ß1 in vivo. FASEB J 14,752-760[Abstract/Free Full Text]
  17. Botchkarev, V. A., Welker, P., Albers, K. M., Botchkareva, N. V., Metz, M., Lewin, G. R., Bulfone-Paus, S., Peters, E. M. J., Lindner, G., Paus, R. (1998) A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen). Am. J. Pathol. 153,705-719
  18. Botchkarev, V. A., Botchkareva, N. V., Welker, P., Metz, M., Subramaniam, A., Lewin, G. R., Braun, A., Lommatzsch, M., Renz, H., Paus, R. (1999) A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control. FASEB J 13,395-410[Abstract/Free Full Text]
  19. Barbacid, M. (1994) The Trk family of neurotrophin receptors. J. Neurobiol. 25,1386-1403[Medline]
  20. Bothwell, M. (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18,223-253[Medline]
  21. Lewin, G. R., Barde, Y. A. (1996) Physiology of the neurotrophins. Annu. Rev. Neurosci. 19,289-317[Medline]
  22. Dechant, G., Tsoulfas, P., Parada, L. F., Barde, Y.-A. (1997) The neurotrophin receptor p75 binds neurotrophin-3 on sympathetic neurons with high affinity and specificity. J. Neurosci. 17,5281-5287[Abstract/Free Full Text]
  23. Carter, B. D., Kaltschmidt, C., Kaltschmidt, B., Offenhauser, N., Bohm Matthaei, R., Baeuerle, P. A., Barde, Y. A. (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272,542-545[Abstract]
  24. Casaccia-Bonnefil, P., Carter, B. D., Dobrowsky, R. T., Chao, M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (London) 383,716-719[Medline]
  25. Frade, J. M., Rodriguez Tebar, A., Barde, Y. A. (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature (London) 383,166-168[Medline]
  26. Yaar, M., Zhai, S., Pilch, P. F., Doyle, S. M., Eisenhauer, P. B., Fine, R. E., Gilchrest, B. A. (1997) Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J. Clin. Invest. 100,2333-2340[Medline]
  27. Yaar, M., Gilchrest, B. A. (1998) Aging versus photoaging: postulated mechanisms and effectors. J. Invest. Dermatol. Symp. Proc. 3,47-51
  28. Bamji, S., Majdan, M., Pozniak, C. D., Belliveau, D., Aloyz, R., Kohn, J., Causing, C. G., Miller, F. D. (1998) The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140,911-923[Abstract/Free Full Text]
  29. Frade, J. M., Barde, Y.-A. (1998) Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 20,35-41[Medline]
  30. Weedon, D., Strutton, G. (1981) Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm. Venereol. 61,335-339[Medline]
  31. Stenn, K. S., Lawrence, L., Veis, D., Korsmeyer, S., Seiberg, M. (1994) Expression of the bcl-2 protooncogene in the cycling adult mouse hair follicle. J. Invest. Dermatol. 103,107-111[Medline]
  32. Soma, T., Ogo, M., Suzuki, J., Takahashi, T., Hibino, T. (1998) Analysis of apoptotic cell death in human hair follicles in vivo and in vitro. J. Invest. Dermatol. 111,948-954[Medline]
  33. Chao, M. V. (1994) The p75 neurotrophin receptor. J. Neurobiol. 25,1373-1385[Medline]
  34. Bothwell, M. (1996) p75(NTR): receptor after all. Science 272,506-507[Medline]
  35. Carter, B., Lewin, G. (1997) Neurotrophins live or let die: does p75NTR decide?. Neuron 18,187-190[Medline]
  36. Dechant, G., Barde, Y.-A. (1997) Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 7,413-418[Medline]
  37. Kaplan, D. R., Miller, F. D. (1997) Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9,213-221[Medline]
  38. Davies, A. (1997) Neurotrophins: the yin and yang of nerve growth factor. Curr. Biol. 7,R38-R40[Medline]
  39. Yoon, S. O., Casaccia-Bonnefil, P., Carter, B., Chao, M. V. (1998) Competitive signalling between TrkA and p75 nerve growth factor receptor determines cell survival. J. Neurosci. 18,3273-3281[Abstract/Free Full Text]
  40. Paus, R., Stenn, K. S., Link, R. E. (1990) Telogen skin contains an inhibitor of hair growth. Br. J. Dermatol. 122,777-784[Medline]
  41. Paus, R., Handjiski, B., Czarnetzki, B. M., Eichmüller, S. (1994) A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J. Invest. Dermatol. 103,143-147[Medline]
  42. Lee, K. F., Li, E., Huber, L. J., Landis, S. C., Sharpe, A. H., Chao, M. V., Jaenish, R. (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficit in the peripheral sensory nervous system. Cell 69,743-749
  43. Albers, K. M., Wright, D. E., Davis, B. M. (1994) Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J. Neurosci. 14,1422-1432[Abstract]
  44. Albers, K. M., Perrone, T. N., Goodness, T. P., Jones, M. E., Green, M. A., Davis, B. M. (1996) Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J. Cell Biol. 134,487-497[Abstract/Free Full Text]
  45. Paus, R., Hofmann, U., Eichmüller, S., Czarnetzki, B. M. (1994) Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br. J. Dermatol. 130,281-289[Medline]
  46. Seidl, K., Erck, C., Buchberger, A. (1998) Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J. Cell. Physiol. 176,10-21[Medline]
  47. Bulfone-Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Rückert, R., Krause, H., Kunzendorf, U. (1997) Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3,1124-1128[Medline]
  48. Philpott, M., Paus, R. (1998) Principles of hair follicle morphogenesis. Chuong, C.-M. eds. Molecular Biology of Epithelial Appendages Morphogenesis ,75-110 Landes Bioscience Austin, Texas.
  49. Li, L., Paus, R., Slominski, A., Hoffman, R. (1992) Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev. Biol. 28,695-698
  50. Paus, R., Lüftl, M., Czarnetzki, B. M. (1994) Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br. J. Dermatol. 130,174-180[Medline]
  51. Handjiski, B. K., Eichmüller, S., Hofmann, U., Czarnetzki, B. M., Paus, R. (1994) Alkaline phosphatase activity and localization during the murine hair cycle. Br. J. Dermatol. 131,303-310[Medline]
  52. Hardy, M. H. (1992) The secret life of the hair follicle. Trends Genet 8,55-61[Medline]
  53. Maurer, M., Fischer, E., Handjiski, B., von Stebut, E., Algermissen, B., Bavandi, A., Paus, R. (1997) Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab. Invest. 77,319-332[Medline]
  54. Chao, M., Casaccia-Bonnefil, P., Carter, B., Chittka, A., Kong, H., Yoon, S. O. (1998) Neurotrophin receptors: mediators of life and death. Brain Res. Rev. 26,295-301[Medline]
  55. Botchkarev, V., Botchkareva, N., Albers, K., van der Veen, C., Lewin, G., Paus, R. (1998) Neurotrophin-3 involvement in the regulation of hair follicle morphogenesis. J. Invest. Dermatol. 111,279-285[Medline]
  56. Botchkareva, N. V., Botchkarev, V. A., Peters, E. M. J., Paus, R. (1998) Nerve growth factor and its receptors in murine skin: expression changes during hair follicle morphogenesis and cycling. Arch. Dermatol. Res. 290,71(abstr.)
  57. Hansen, L. S., Coggle, J. E., Wells, J., Charles, M. W. (1984) The influence of the hair cycle on the thickness of mouse skin. Anat. Rec. 210,569-573[Medline]
  58. Maurer, M., Handjiski, B., Paus, R. (1997) Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am. J. Pathol. 150,1433-1441[Abstract]
  59. Fuchs, E. (1995) Keratins and the skin. Annu. Rev. Cell Dev. Biol. 11,123-153[Medline]
  60. Commo, S., Bernard, B. A. (1997) Immunohistochemical analysis of tissue remodelling during the anagen–catagen transition of the human hair follicle. Br. J. Dermatol. 137,31-38[Medline]
  61. Bowden, P. E., Hainey, S. D., Parker, G., Jones, D. O., Zimonjic, D., Popescu, N., Hodgins, M. (1998) Characterization and chromosomal localization of human hair-specific keratin genes and comparative expression during the hair growth cycle. J. Invest. Dermatol. 110,158-164[Medline]
  62. Fundin, B. T., Silos-Santiago, I., Ernfors, P., Fagan, A. M., Aldskogius, H., DeChiara, T. M., Phillips, H., Barbacid, M., Yancopoulos, G. D., Rice, F. L. (1997) Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR. Dev. Biol. 190,94-116[Medline]
  63. Bergmann, I., Priestley, J. V., McMahon, S. B., Brocker, E. B., Toyka, K. V., Koltzenburg, M. (1997) Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75. Eur. J. Neurosci. 9,18-28[Medline]
  64. Rice, F. L., Albers, K. M., Davis, B. M., Silos-Santiago, I., Wilkinson, G. A., LeMaster, A. M., Ernfors, P., Smeyne, R. J., Aldskogius, H., Philips, H. S., Barbacid, M., DeChiara, T. M., Yancopoulos, G. D., Dunne, C. E., Fundin, B. T. (1998) Differential dependency of unmyelinated and A{delta} epidermal and upper dermal innervation on neurotrophins, trk receptors and p75 LNGFR. Dev. Biol. 198,57-81[Medline]
  65. Paus, R., Handjiski, B., Eichmüller, S., Czarnetzki, B. M. (1994) Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am. J. Pathol. 144,719-734[Abstract]
  66. Cece, R., Cazzaniga, S., Morelli, D., Sfondrini, L., Bignotto, M., Menard, S., Colnaghi, M. I., Balsari, A. (1996) Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats. Lab. Invest. 75,601-609[Medline]
  67. Panteleyev, A. A., van der Veen, C., Rosenbach, T., Muller Rover, S., Sokolov, V. E., Paus, R. (1998) Towards defining the pathogenesis of the hairless phenotype. J. Invest. Dermatol. 110,902-907[Medline]
  68. Panteleyev, A. A., Botchkareva, N. V., Sandberg, J., Christiano, A., Paus, R. (1999) Pathobiology of the hairless phenotype: dysregulation of intrafollicular apoptosis and topobiology during the initiation of hair follicle cycling. Am. J. Pathol. 155,159-171[Abstract/Free Full Text]
  69. Huang, E. J., Zang, K., Schmidt, A., Saulys, A., Xiang, M., Reichardt, L. F. (1999) POU domain factor Brn-3a controls the differentiation and survival of trigeminal neurons by regulating Trk receptor expression. Development 126,2869-2882[Abstract]
  70. Poukka, H., Kallio, P. J., Janne, O. A., Palvimo, J. J. (1996) Regulation of the rat p75 neurotrophin receptor promoter by GC element binding proteins. Biochem. Biophys. Res. Commun. 229,565-570[Medline]
  71. Botchkarev, V. A., Botchkareva, N. V., Roth, W., Nakamura, M., Chen, L.-H., Herzog, W., Lindner, G., McMahon, J. A., Peters, C., Lauster, R., McMahon, A. P., Paus, R. (1999) Noggin is a mesenchymally-derived stimulator of hair follicle induction. Nature Cell Biol 1,158-164[Medline]
  72. Pincelli, C., Haake, A. R., Benassi, L., Grassilli, E., Magoni, C., Ottani, D., Polakowska, R., Franceschi, C., Gianetti, A. (1997) Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (Trk): a role for Bcl-2. J. Invest. Dermatol. 109,757-764[Medline]
  73. Muragaki, Y., Chou, T. T., Kaplan, D. R., Trojanowski, J. Q., Lee, V. M. Y. (1997) Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express Trka receptors. J. Neurosci. 17,530-542[Abstract/Free Full Text]
  74. Chou, T. T., Trojanowski, J. Q., Lee, V. M.-Y. (1997) Neurotrophin signal transduction in medulloblastoma. J. Neurosci. Res. 49,522-527[Medline]
  75. Bronzetti, E., Ciraco, E., Germana, G., Vega, J. A. (1996) Immunocytochemical localization of neurotrophin receptor proteins in human skin. Ital. J. Anat. Embryol. 100(Suppl. 1),565-571
  76. Shibayama, E., Koizumi, H. (1996) Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am. J. Pathol. 148,1807-1818[Abstract]



This article has been cited by other articles:


Home page
Poult. Sci.Home page
W. Wu, R. F. Xu, L. Xiao, H. Xu, and G. Gao
Expression of the -Catenin Gene in the Skin of Embryonic Geese During Feather Bud Development
Poult. Sci., January 1, 2008; 87(1): 204 - 211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. M.J. Peters, S. Liotiri, E. Bodo, E. Hagen, T. Biro, P. C. Arck, and R. Paus
Probing the Effects of Stress Mediators on the Human Hair Follicle: Substance P Holds Central Position
Am. J. Pathol., December 1, 2007; 171(6): 1872 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Y. Fessing, T. Y. Sharova, A. A. Sharov, R. Atoyan, and V. A. Botchkarev
Involvement of the Edar Signaling in the Control of Hair Follicle Involution (Catagen)
Am. J. Pathol., December 1, 2006; 169(6): 2075 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. Ohnemus, M. Uenalan, J. Inzunza, J.-A. Gustafsson, and R. Paus
The Hair Follicle as an Estrogen Target and Source
Endocr. Rev., October 1, 2006; 27(6): 677 - 706.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Physiol Rev, October 1, 2006; 86(4): 1309 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. M.J. Peters, S. Hendrix, G. Golz, B. F. Klapp, P. C. Arck, and R. Paus
Nerve Growth Factor and its Precursor Differentially Regulate Hair Cycle Progression in Mice
J. Histochem. Cytochem., March 1, 2006; 54(3): 275 - 288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. M.J. Peters, M. G. Stieglitz, C. Liezman, R. W. Overall, M. Nakamura, E. Hagen, B. F. Klapp, P. Arck, and R. Paus
p75 Neurotrophin Receptor-Mediated Signaling Promotes Human Hair Follicle Regression (Catagen)
Am. J. Pathol., January 1, 2006; 168(1): 221 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Bodo, T. Biro, A. Telek, G. Czifra, Z. Griger, B. I. Toth, A. Mescalchin, T. Ito, A. Bettermann, L. Kovacs, et al.
A Hot New Twist to Hair Biology: Involvement of Vanilloid Receptor-1 (VR1/TRPV1) Signaling in Human Hair Growth Control
Am. J. Pathol., April 1, 2005; 166(4): 985 - 998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. A. Sharov, F. Siebenhaar, T. Y. Sharova, N. V. Botchkareva, B. A. Gilchrest, and V. A. Botchkarev
Fas Signaling Is Involved in the Control of Hair Follicle Response to Chemotherapy
Cancer Res., September 1, 2004; 64(17): 6266 - 6270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. G. Rossler and G. Thiel
Brain-derived neurotrophic factor-, epidermal growth factor-, or A-Raf-induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1118 - C1129.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
V. A. BOTCHKAREV, N. V. BOTCHKAREVA, M. NAKAMURA, O. HUBER, K. FUNA, R. LAUSTER, R. PAUS, and B. A. GILCHREST
Noggin is required for induction of the hair follicle growth phase in postnatal skin
FASEB J, October 1, 2001; 15(12): 2205 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. A. Botchkarev, E. A. Komarova, F. Siebenhaar, N. V. Botchkareva, A. A. Sharov, P. G. Komarov, M. Maurer, A. V. Gudkov, and B. A. Gilchrest
p53 Involvement in the Control of Murine Hair Follicle Regression
Am. J. Pathol., June 1, 2001; 158(6): 1913 - 1919.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS